{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:14:11Z","timestamp":1762323251577,"version":"3.37.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1097\/fbp.0b013e3283243008","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T08:15:57Z","timestamp":1233216957000},"page":"84-98","source":"Crossref","is-referenced-by-count":26,"title":["Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus"],"prefix":"10.1097","volume":"20","author":[{"given":"Ming","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa","family":"Mead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210202","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3565(25)23394-8","article-title":"Effects of chlorpromazine on the acquisition and extinction of an avoidance response in the rat","volume":"131","author":"Ader","year":"1957","journal-title":"J Pharmacol Exp Ther"},{"key":"R2-8-20210202","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0773.1982.tb01032.x","article-title":"Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade","volume":"51","author":"Arnt","year":"1982","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"R3-8-20210202","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/mi.2.8.470","article-title":"The emergence of behavioral pharmacology","volume":"2","author":"Barrett","year":"2002","journal-title":"Mol Intervent"},{"key":"R4-8-20210202","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1124\/jpet.108.139261","article-title":"Dews and pharmacological studies on behavior","volume":"326","author":"Barrett","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"R5-8-20210202","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1192\/bjp.111.477.701","article-title":"Comparison of amphetamine psychosis and schizophrenia","volume":"111","author":"Bell","year":"1965","journal-title":"Br J Psychiatry"},{"key":"R6-8-20210202","first-page":"265","article-title":"Aversion, avoidance, and anxiety: perspective on aversively motivated behavior","author":"Beninger","year":"1989"},{"key":"R7-8-20210202","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0165-0173(98)00019-8","article-title":"What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?","volume":"28","author":"Berridge","year":"1998","journal-title":"Brain Res Brain Res Rev"},{"key":"R8-8-20210202","first-page":"385","article-title":"Psychopharmacology of aversively motivated behavior","author":"Bignami","year":"1978"},{"key":"R9-8-20210202","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF00427424","article-title":"Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment","volume":"83","author":"Bruto","year":"1984","journal-title":"Psychopharmacology (Berl)"},{"key":"R10-8-20210202","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.biopsych.2004.12.019","article-title":"Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex","volume":"57","author":"Castner","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R11-8-20210202","first-page":"563","article-title":"Psychopharmacology:a generation of progress","author":"Cook","year":"1978."},{"key":"R12-8-20210202","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1976.tb27919.x","article-title":"Interactions of behavioral effects of drugs","volume":"281","author":"Dews","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"R13-8-20210202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbr.2006.08.028","article-title":"Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance","volume":"175","author":"Dunn","year":"2006","journal-title":"Behav Brain Res"},{"key":"R14-8-20210202","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00008877-200006000-00006","article-title":"Animal models for the negative symptoms of schizophrenia","volume":"11","author":"Ellenbroek","year":"2000","journal-title":"Behav Pharmacol"},{"key":"R15-8-20210202","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.pnpbp.2007.08.025","article-title":"The amphetamine-induced sensitized state as a model of schizophrenia","volume":"31","author":"Featherstone","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R16-8-20210202","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00213-005-0157-6","article-title":"Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex","volume":"183","author":"Fletcher","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"R17-8-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"R18-8-20210202","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/070674376701200217","article-title":"Effect of phencyclidine in chronic schizophrenics","volume":"12","author":"Itil","year":"1967","journal-title":"Can Psychiatr Assoc J"},{"key":"R19-8-20210202","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00491982","article-title":"Amphetamine psychosis and psychotic symptoms","volume":"65","author":"Janowsky","year":"1979","journal-title":"Psychopharmacology (Berl)"},{"key":"R20-8-20210202","first-page":"104","article-title":"Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data?","volume":"15","author":"Janssen","year":"1965","journal-title":"Arzneimittelforschung"},{"key":"R21-8-20210202","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"R22-8-20210202","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00213-004-1772-3","article-title":"A low dose of the alpha2 agonist clonidine ameliorates the visual attention and spatial working memory deficits produced by phencyclidine administration to rats","volume":"175","author":"Jentsch","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"R23-8-20210202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"R24-8-20210202","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0893-133X(00)00174-3","article-title":"Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats","volume":"24","author":"Jentsch","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"R25-8-20210202","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0893-133X(97)00034-1","article-title":"Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat","volume":"17","author":"Jentsch","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"R26-8-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","article-title":"Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia","volume":"160","author":"Kapur","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R27-8-20210202","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.med.52.1.503","article-title":"Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia","volume":"52","author":"Kapur","year":"2001","journal-title":"Annu Rev Med"},{"key":"R28-8-20210202","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"R29-8-20210202","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0091-3057(81)90241-0","article-title":"Correlation between antiavoidance activities of antipsychotic drugs in rats and daily clinical doses","volume":"14","author":"Kuribara","year":"1981","journal-title":"Pharmacol Biochem Behav"},{"key":"R30-8-20210202","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.pbb.2004.05.023","article-title":"Evaluation of the motor initiation hypothesis of APD-induced conditioned avoidance decreases","volume":"78","author":"Li","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"R31-8-20210202","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.npp.1301110","article-title":"Time course of the antipsychotic effect and the underlying behavioral mechanisms","volume":"32","author":"Li","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R32-8-20210202","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/sj.npp.1300700","article-title":"Alpha-2 adrenoceptor activation inhibits phencyclidine-induced deficits of spatial working memory in rats","volume":"30","author":"Marrs","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"R33-8-20210202","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.biopsych.2005.02.005","article-title":"Sensitized attentional performance and Fos-immunoreactive cholinergic neurons in the basal forebrain of amphetamine-pretreated rats","volume":"57","author":"Martinez","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R34-8-20210202","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00213-002-1185-0","article-title":"Continuing implications of the early evidence against the drive-reduction hypothesis of the behavioral effects of drugs","volume":"163","author":"McMillan","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"R35-8-20210202","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1037\/0735-7044.115.6.1247","article-title":"Latent inhibition, but not prepulse inhibition, is reduced during withdrawal from an escalating dosage schedule of amphetamine","volume":"115","author":"Murphy","year":"2001","journal-title":"Behav Neurosci"},{"key":"R36-8-20210202","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/00223980209604159","article-title":"Phencyclidine (PCP): a dangerous drug, but useful in schizophrenia research","volume":"136","author":"Murray","year":"2002","journal-title":"J Psychol"},{"key":"R37-8-20210202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/105504901750532094","article-title":"Molecular neurobiology of addiction","volume":"10","author":"Nestler","year":"2001","journal-title":"Am J Addict"},{"key":"R38-8-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbr.2007.07.034","article-title":"Effects of withdrawal from an escalating dose of amphetamine on conditioned fear and dopamine response in the medial prefrontal cortex","volume":"186","author":"Peleg-Raibstein","year":"2008","journal-title":"Behav Brain Res"},{"key":"R39-8-20210202","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1017\/S1461145706006493","article-title":"Differential effects on prepulse inhibition of withdrawal from two different repeated administration schedules of amphetamine","volume":"9","author":"Peleg-Raibstein","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"R40-8-20210202","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0028-3908(02)00022-9","article-title":"Increased conditioned fear response and altered balance of dopamine in the shell and core of the nucleus accumbens during amphetamine withdrawal","volume":"42","author":"Pezze","year":"2002","journal-title":"Neuropharmacology"},{"key":"R41-8-20210202","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0022-3565(24)38833-0","article-title":"Pharmacological characterization of locomotor sensitization induced by chronic phencyclidine administration","volume":"296","author":"Phillips","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"R42-8-20210202","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","article-title":"Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis","volume":"396","author":"Robinson","year":"1986","journal-title":"Brain Res"},{"key":"R43-8-20210202","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1460-9568.2005.03937.x","article-title":"PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats","volume":"21","author":"Rodefer","year":"2005","journal-title":"Eur J Neurosci"},{"key":"R44-8-20210202","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0893-133X(01)00422-5","article-title":"Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal","volume":"26","author":"Russig","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"R45-8-20210202","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00213-002-1254-4","article-title":"Prepulse inhibition during withdrawal from an escalating dosage schedule of amphetamine","volume":"169","author":"Russig","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"R46-8-20210202","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0893-133X(97)00200-5","article-title":"Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats","volume":"19","author":"Sams-Dodd","year":"1998a","journal-title":"Neuropsychopharmacology"},{"key":"R47-8-20210202","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0893-133X(97)00161-9","article-title":"A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine","volume":"18","author":"Sams-Dodd","year":"1998b","journal-title":"Neuropsychopharmacology"},{"key":"R48-8-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0166-4328(02)00282-6","article-title":"Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine","volume":"137","author":"Salamone","year":"2002","journal-title":"Behav Brain Res"},{"key":"R49-8-20210202","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0091-3057(74)90060-4","article-title":"Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy","volume":"2","author":"Segal","year":"1974","journal-title":"Pharmacol Biochem Behav"},{"key":"R50-8-20210202","first-page":"95","article-title":"Stimulant-induced psychosis: an evaluation of animal methods","volume":"5","author":"Segal","year":"1981","journal-title":"Essays Neurochem Neuropharmacol"},{"key":"R51-8-20210202","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0022-3565(24)34979-1","article-title":"Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats","volume":"290","author":"Shannon","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"R52-8-20210202","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1176\/ajp.130.1.61","article-title":"Amphetamine psychosis: a \u2018model\u2019 schizophrenia mediated by catecholamines","volume":"130","author":"Snyder","year":"1973","journal-title":"Am J Psychiatry"},{"key":"R53-8-20210202","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3565(25)33440-3","article-title":"Behavioral effects of clozapine: comparison with thioridazine, chlorpromazine, haloperidol and chlordiazepoxide in squirrel monkeys","volume":"224","author":"Spealman","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"R54-8-20210202","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0920-9964(03)00009-4","article-title":"Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia","volume":"64","author":"Tenn","year":"2003","journal-title":"Schizophr Res"},{"key":"R55-8-20210202","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00213-005-2253-z","article-title":"Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition","volume":"180","author":"Tenn","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"R56-8-20210202","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0166-4328(88)90158-1","article-title":"A rapidly acquired one-way conditioned avoidance procedure in rats as a primary screening test for antipsychotics: influence of shock intensity on avoidance performance","volume":"31","author":"Van der Heyden","year":"1988","journal-title":"Behav Brain Res"},{"key":"R57-8-20210202","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0149-7634(99)00037-8","article-title":"The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?","volume":"23","author":"Wadenberg","year":"1999","journal-title":"Neurosci Biobehav Rev"},{"key":"R58-8-20210202","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, learning and motivation","volume":"5","author":"Wise","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"R59-8-20210202","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0091-3057(94)90165-1","article-title":"Phencyclidine-induced behavioral sensitization","volume":"47","author":"Xu","year":"1994","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00008877-200902000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T08:32:31Z","timestamp":1738917151000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-200902000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0b013e3283243008","relation":{},"ISSN":["0955-8810"],"issn-type":[{"type":"print","value":"0955-8810"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}